Search

Displaying results 4331 - 4340 of 7452 in total
  1. Drug

    Mannose

    go.drugbank.com/drugs/DB12907
    Investigational

    Mannose is under investigation for the basic science of IUGR and Pregnancy.

  2. Drug

    Hypericin

    go.drugbank.com/drugs/DB13014
    Investigational

    Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma.

  3. Drug

    Mapracorat

    go.drugbank.com/drugs/DB12041
    Investigational

    Mapracorat has been investigated for the treatment of Eczema and Atopic Dermatitis.

  4. Drug

    Losmapimod

    go.drugbank.com/drugs/DB12270
    Investigational

    Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.

  5. Drug

    Salvinorin A

    go.drugbank.com/drugs/DB12327
    Investigational

    Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations.

  6. Drug

    Urapidil

    go.drugbank.com/drugs/DB12661
    Investigational

    Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.

  7. Drug

    UDP-alpha-D-glucuronic acid

    go.drugbank.com/drugs/DB03041
    Experimental

    A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. … In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. [PubChem]

  8. Drug

    Arbaclofen Placarbil

    go.drugbank.com/drugs/DB08892
    Investigational

    On May 20th, 2013, XenoPort announced plans to terminate the development of Arbaclofen Placerbil for the treatment of multiple sclerosis. … It was discovered, and has been patented by XenoPort as a new chemical entity with an improved pharmacokinetic profile compared to baclofen, which allows for sustained release properties.

  9. Drug

    Aluminum acetate

    go.drugbank.com/drugs/DB14518
    ApprovedInvestigational

  10. Drug

    EGS21

    go.drugbank.com/drugs/DB05056
    Experimental

    It is a potential therapeutic for treating immune mediated disorders. … and therefore is being evaluated as an important candidate drug in the treatment of various immune mediated diseases, such as Crohn's disease, hepatitis, non-alcoholic steatohepatitis (NASH) or